Aquestive Therapeutics Files 8-K
Ticker: AQST · Form: 8-K · Filed: Apr 1, 2025 · CIK: 1398733
| Field | Detail |
|---|---|
| Company | Aquestive Therapeutics, Inc. (AQST) |
| Form Type | 8-K |
| Filed Date | Apr 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, exhibits, sec-filing
Related Tickers: AQST
TL;DR
AQST filed an 8-K on 4/1/25. Financials & exhibits updated.
AI Summary
Aquestive Therapeutics, Inc. filed an 8-K on April 1, 2025, reporting on financial statements and exhibits. The company, formerly known as MonoSol Rx, Inc., is incorporated in Delaware and headquartered in Warren, NJ.
Why It Matters
This filing provides an update on the company's financial reporting and exhibits, which can be crucial for investors to assess the company's current financial health and strategic direction.
Risk Assessment
Risk Level: low — This is a routine filing of financial statements and exhibits, not indicating any immediate material adverse events.
Key Numbers
- 001-38599 — SEC File Number (Identifies the company's filing with the SEC)
- 82-3827296 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Aquestive Therapeutics, Inc. (company) — Registrant
- MonoSol Rx, Inc. (company) — Former company name
- April 1, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Warren, NJ (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on financial statements and exhibits as of April 1, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on April 1, 2025.
What is Aquestive Therapeutics, Inc.'s state of incorporation?
Aquestive Therapeutics, Inc. is incorporated in Delaware.
What are the principal executive offices of Aquestive Therapeutics, Inc.?
The principal executive offices of Aquestive Therapeutics, Inc. are located at 30 Technology Drive, Warren, NJ 07059.
What was Aquestive Therapeutics, Inc.'s former company name?
Aquestive Therapeutics, Inc.'s former company name was MonoSol Rx, Inc.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding Aquestive Therapeutics, Inc. (AQST).